$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
帕博西林多少钱一个疗程?
2025-10-19 11:44:20
Check Details
乳腺癌患者服用帕博西林治疗的效果
2025-10-19 11:44:20
Check Details
转移性乳腺癌用药帕博西林效果怎么样?
2025-10-19 11:44:20
Check Details
帕博西林2020价格
2025-10-19 11:44:20
Check Details
乳腺癌药物帕博西林多少钱一盒?
2025-10-19 11:44:20
Check Details
抗癌药拉罗替尼价格多少钱
2025-10-19 11:44:20
Check Details
抗癌药拉罗替尼进入医保了吗
2025-10-19 11:44:20
Check Details
抗癌药拉罗替尼进医保了吗
2025-10-19 11:44:20
Check Details
抗癌药拉罗替尼抗癌效果好不好
2025-10-19 11:44:20
Check Details
抗癌药拉罗替尼抗癌效果怎么样
2025-10-19 11:44:20
Check Details
抗癌药拉罗替尼耐药了怎么办
2025-10-19 11:44:20
Check Details
抗癌药拉罗替尼是哪个国家
2025-10-19 11:44:20
Check Details
1
2
...
1931
1932
1933
1934
1935
1936
1937
...
4157
4158
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Dabrafenib Clinical Guide: Indications, Combination Strategies, and BRAF Inhibitor Comparisons
2
Cabozantinib Capsules: A Multi-Targeted Therapy for Progressive Medullary Thyroid Cancer
3
Lorlatinib: Mechanism, Advantages, and Key Considerations of Third-Generation ALK Inhibitor Therapy in ALK-Positive NSCLC
4
Pemigatinib Side Effects Explained: Managing Adverse Reactions of FGFR-Targeted Therapy in Cholangiocarcinoma
5
Selpercatinib: Before or After Meals? A Complete Guide to RET-Targeted Therapy Administration
6
Mitotane for Adrenocortical Carcinoma: Dosing Guidelines and Therapeutic Drug Monitoring
7
Leflunomide and Ocular Adverse Effects: Risk Awareness and Clinical Guidance
8
Clinical Management of Acquired Resistance to Garsorasib (KRAS G12C Inhibitor)
9
Chemical Structure of Capivasertib: A Novel AKT Inhibitor
10
Capivasertib: An AKT Inhibitor for Breast and Prostate Cancer
11
Global Update 2026: Selumetinib (KOSELUGO) Expands Indication to Adult NF1-PN and Clinical Management Strategies
12
Lenvatinib Safety Guide: Baseline Assessment & Adverse Reaction Management